易华录（300212.SZ）12月11日在投资者互动平台表示，公司牵头的"TB级纳米光信息存储"国家重点研 发项目正在顺利推进，该技术尚不具备量产条件，具体相关情况请您持续关注公司公开披露信息。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：公司牵头的"TB级纳米光信息存储"国家重点研发项目 当前进展如何？该技术是否已具备量产条件？ ...

融券方面，易华录12月4日融券偿还3.84万股，融券卖出1.23万股，按当日收盘价计算，卖出金额21.62 万元；融券余量24.88万股，融券余额437.39万元，低于近一年50%分位水平，处于较低位。 资料显示，北京易华录信息技术股份有限公司位于北京市石景山区阜石路165号院华录大厦，成立日期 2001年4月30日，上市日期2011年5月5日，公司主营业务涉及通过自主研发的集成指挥平台系统软件 ATMS,以承接智能交通管理系统工程的方式为用户提供专业化、个性化的智能交通管理整体解决方案。 主营业务收入构成为：数字化系统及底座59.45%，数据运营及服务40.55%。 截至11月20日，易华录股东户数6.86万，较上期增加0.43%；人均流通股10186股，较上期减少0.43%。 2025年1月-9月，易华录实现营业收入4.15亿元，同比减少3.91%；归母净利润-5.35亿元，同比增长 12.78%。 12月4日，易华录跌0.06%，成交额1.54亿元。两融数据显示，当日易华录获融资买入额1118.89万元， 融资偿还1526.98万元，融资净买入-408.10万元。截至12月4日，易华录融资融券余额合计6 ...

Group 1: Industry Insights - The National Bureau of Statistics emphasizes the importance of enabling artificial intelligence development through data element empowerment as a key focus of market-oriented reform in the data element sector [1] - By July 2025, a comprehensive market structure is expected to form, led by one national exchange and over 50 regional and industry-level institutions, with the data trading market projected to grow to 211.54 billion yuan by 2024 [1] - The market size is anticipated to reach 284.09 billion yuan by 2025 and potentially exceed 715.9 billion yuan by 2030, with a compound annual growth rate of 20.3% during this period [1] - The construction of an open, shared, and secure national integrated data market is expected to accelerate data circulation and unlock the value of data elements, benefiting the entire industry chain [1] Group 2: Company Developments - Yihualu is recognized as a pioneer in the data element industry with a central enterprise background, actively participating in the development of national standards and industry norms [2] - The company provides a full-process service for data element assetization to government and enterprise clients, covering data asset evaluation, registration, authorized operation, and regional data element market construction [2] - Yihualu has established a complete business chain that includes data registration, asset evaluation, and circulation operation, creating a "public data operation platform product system" to attract industry users and technology service providers [2] - Shanghai Steel Union possesses a significant amount of exclusive bulk commodity data [3]

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

Core Viewpoint - The company has decided to transfer a 35% stake in its subsidiary, Liaoyun Information Technology Co., Ltd., through a public listing on the Beijing Property Exchange, aiming to optimize its equity structure and enhance asset liquidity [1][2] Group 1 - The transfer of the stake is based on the company's development plan and is intended to provide cash flow support for its operations [2] - The estimated value of the total equity of Liaoyun Company as of the assessment base date is -43.6478 million yuan, with the minimum transfer price set at no less than 14.7806 million yuan [1] - The company has publicly listed stakes in four other subsidiaries over the past twelve months, but none have been successfully transacted as of the announcement date [2]

Core Viewpoint - Yihualu (300212.SZ) plans to transfer 35% of its stake in Shandong Liaoyun Information Technology Co., Ltd. through a public listing on the Beijing Property Exchange, after which the company will no longer hold shares in Liaoyun [1] Group 1 - The transfer of Liaoyun's equity is a strategic decision aimed at optimizing the subsidiary's equity structure and enhancing asset liquidity [1] - The proceeds from this transaction will provide cash flow support for the company's operational development [1]

人民财讯12月2日电，易华录（300212）12月2日公告，公司拟通过北京产权交易所公开挂牌的方式，转 让参股公司山东聊云信息技术有限责任公司(下称"聊云信息")35%的股权，转让完成后公司将不再持有 聊云信息的股份。 ...

Group 1 - The core point of the article is that Beijing EasyHualu Information Technology Co., Ltd. plans to transfer 35% of its stake in Shandong Liaoyun Information Technology Co., Ltd. through a public listing on the Beijing Property Exchange, after which the company will no longer hold any shares in Liaoyun [1] Group 2 - The sixth board meeting of the company will be held on December 2, 2025, to review the proposal for the transfer of shares [1]

Core Viewpoint - The company plans to transfer a 35% stake in its affiliate, Shandong Liaoyun Information Technology Co., Ltd., through a public listing on the Beijing Property Exchange, resulting in the company no longer holding any shares in Liaoyun [1] Financial Summary - As of May 31, 2025, Liaoyun's total assets were 248 million yuan, total liabilities were 304 million yuan, and net assets were -56.93 million yuan, with operating revenue of 1.84 million yuan and a net loss of 65.92 million yuan [1] - For the year ending December 31, 2024, Liaoyun reported total assets of 312 million yuan, total liabilities of 303 million yuan, net assets of 8.99 million yuan, operating revenue of 5.81 million yuan, and a net loss of 32.15 million yuan [1] - The operating cash flow for the first five months of 2025 was -61,700 yuan, while for the entire year of 2024, it was -2.22 million yuan [1]

| 证券代码：300212 | 证券简称：易华录 | | 公告编号：2025-055 | | --- | --- | --- | --- | | 债券代码：148002 | 债券简称：22 | 华录 01 | | 经审议，董事会同意通过北京产权交易所公开挂牌的方式转让参股公司山东 聊云信息技术有限责任公司（下称"聊云公司"）35%的股权，转让完成后公司将 不再持有聊云公司的股份。本次交易所取得转让款将为公司经营发展提供现金流 支持。本次交易对于公司正常生产经营不存在重大影响，不存在损害公司及全体 股东、特别是中小股东利益的情形。 表决结果：同意 9 票，反对 0 票，弃权 0 票获得通过。 特此公告。 北京易华录信息技术股份有限公司董事会 2025 年 12 月 2 日 北京易华录信息技术股份有限公司 第六届董事会第十七次会议决议 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 北京易华录信息技术股份有限公司（以下简称"公司"或"易华录"）第六 届董事会第十七次会议于 2025 年 12 月 2 日（星期二）以现场会议及通讯会议的 方式在公司十楼会议室召开，会 ...